Fluphenazine structure
|
Common Name | Fluphenazine | ||
|---|---|---|---|---|
| CAS Number | 69-23-8 | Molecular Weight | 437.522 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 568.3±50.0 °C at 760 mmHg | |
| Molecular Formula | C22H26F3N3OS | Melting Point | 268-274℃ | |
| MSDS | N/A | Flash Point | 297.5±30.1 °C | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
Use of FluphenazineFluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine is used for the research of schizophrenia. Fluphenazine blocks neuronal voltage-gated sodium channels[1]. |
| Name | fluphenazine |
|---|---|
| Synonym | More Synonyms |
| Description | Fluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine is used for the research of schizophrenia. Fluphenazine blocks neuronal voltage-gated sodium channels[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 568.3±50.0 °C at 760 mmHg |
| Melting Point | 268-274℃ |
| Molecular Formula | C22H26F3N3OS |
| Molecular Weight | 437.522 |
| Flash Point | 297.5±30.1 °C |
| Exact Mass | 437.174866 |
| PSA | 55.25000 |
| LogP | 4.84 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.579 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Hazard Codes | F,T |
| Risk Phrases | 11-23/24/25-39/23/24/25 |
| Safety Phrases | 16-36/37-45 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
|
~%
Fluphenazine CAS#:69-23-8 |
| Literature: Journal of Pharmaceutical Sciences, , vol. 67, # 2 p. 157 - 162 |
|
~%
Fluphenazine CAS#:69-23-8 |
| Literature: Journal of Pharmaceutical Sciences, , vol. 67, # 2 p. 157 - 162 |
|
~%
Fluphenazine CAS#:69-23-8 |
| Literature: Arzneimittel Forschung, , vol. 12, p. 937 - 942 |
|
~%
Fluphenazine CAS#:69-23-8 |
| Literature: Arzneimittel Forschung, , vol. 12, p. 937 - 942 |
|
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
J. Psychosoc. Nurs. Ment. Health Serv. 51(3) , 13-8, (2013) Medication nonadherence has been associated with persistence of psychotic symptoms, relapse, and hospitalization in patients with schizophrenia. Patients with untreated psychosis are significantly les... |
|
|
Latent inhibition in an insect: the role of aminergic signaling.
Learn. Mem. 19(12) , 593-7, (2012) Latent inhibition (LI) is a decrement in learning performance that results from the nonreinforced pre-exposure of the to-be-conditioned stimulus, in both vertebrates and invertebrates. In vertebrates,... |
|
|
[Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].
Invest. Clin. 54(1) , 47-57, (2013) Wilson disease is a hereditary disorder caused by mutations of the ATP7B gene, which leads to intoxication with copper as a result of an unbalance of copper homeostasis. The clinical manifestations re... |
| 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)- |
| 2-{4-[3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol |
| hiazine |
| dapotum |
| 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-Piperazineethanol |
| Sevinol |
| Elinol |
| Pacinol |
| 10-[3'-[4''-(b-Hydroxyethyl)-1''-piperazinyl]propyl]-3-trifluoromethylphenothiazine |
| 2-(Trifluoromethyl)-10-[3-[1-(b-hydroxyethyl)-4-piperazinyl]propyl]phenothiazine |
| 4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol |
| 4-[3-[2-(trifluoromethyl)phenothiazine-10-yl]propyl]-1-piperazineethanol |
| S 94 |
| 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol |
| Fluphenazine |
| 2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol |
| 1-Piperazineethanol, 4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]- |
| 2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethanol |
| 1-(2-Hydroxyethyl)-4-[3-(trifluoromethyl-10-phenothiazinyl)propyl]piperazine |